Xianqi Kong

This inventor holds 42 USPTO granted patents and 24 published patent applications, plus 3 CIPO patents and 5 EPO patents, primarily in Isotope Chemistry. Top assignees: Risen (Suzhou) Pharma Tech Co., Ltd., Neurochem (International) Limited, Bhi Limited Partnership. Active years: 1999-2026.

USPTO Granted Patents = 42 (Patent Applications = 24)

% Patents Active = 61.9

CIPO Patents = 3 (Patent Applications = 17)

EPO Patents = 5 (Patent Applications = 3)

Average Co-Inventor Count = 5.3

ph-index = 10

Forward Citations = 250(Granted Patents)

Location History:

Kingston, CA (1999)
Suzhou, CN (2021 - 2023)
Dollard-des-Ormeaux, CA (2001 - 2024)

Company Filing History:

15 out of 16

Risen (Suzhou) Pharma Tech Co., Ltd.

patents

6 out of 9

Neurochem (International) Limited

patents

5 out of 5

Bhi Limited Partnership

Queen's University at Kingston

patents

6. 4 out of 4

Risen (Suzhou) Pharma Tech Co., Ltd.

patents

7. 3 out of 6

Shanghai Junshi Biosciences Co., Ltd.

patents

8. 2 out of 3

Bellus Health (International) Limited

Shanghai Junshi Biosciences Inc.

patents

11. 1 out of 1

Shanghai Junshl Biosciences Co., Ltd.

patent

12. 2 out of 834,411

Other

patents

where one patent can have more than one assignee

Years Active: 1999-2026

Loading Chart...

Areas of Expertise:

Isotope-Enriched Compounds

Glucosamine Derivatives

Amyloid-Related Diseases

CDK Inhibitors

Pharmaceutical Uses

Prodrugs

Amino Acid Derivatives

Cerebrovascular Disease

Joint Disorders

Neuropathic Pain

Pharmaceutical Drug Candidates

Heavy Isotopes

42 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12673969 - CD73 inhibitors and pharmaceutical uses thereof (2026-07-07),

2. 12637441 - Prodrugs of the tyrosine kinase inhibitor for treating cancer (2026-05-26),

3. 12595260 - Stable heavy isotopes in amide functional groups and uses thereof (2026-04-07),

4. 12552823 - Glucosamine derivatives and pharmaceutical uses thereof (2026-02-17),

5. 12459888 - Isotope-enriched 3-amino-1-propanesulfonic acid derivatives and uses thereof (2025-11-04),

6. 12403129 - Isotope-enriched 3-amino-1-propanesulfonic acid derivatives for the treatment of cerebrovascular disease (2025-09-02),

7. 12365675 - Stable heavy isotopes in amide functional groups and uses thereof (2025-07-22),

8. 12312378 - Glucosamine derivatives for the prevention or treatment of joint disorders (2025-05-27),

9. 11970490 - Stable heavy isotopes in amide functional groups and uses thereof (2024-04-30),

10. 11725020 - Prodrugs of a CDK inhibitor for treating cancers (2023-08-15),

11. 11718636 - Glucosamine derivatives for the prevention or treatment of joint disorders (2023-08-08),

12. 11608314 - Crystalline form of 3-((L-valyl) amino))-3, 3-dideuterium-1-propanesulfonic acid, preparation method and uses thereof (2023-03-21),

13. 11591358 - Glucosamine derivatives and pharmaceutical uses thereof (2023-02-28),

14. 11530234 - CD73 inhibitors and pharmaceutical uses thereof (2022-12-20),

15. 11225497 - Prodrugs of a CDK inhibitor for treating cancers (2022-01-18),

Title: Xianqi Kong - Inventor from Dollard-des-Ormeaux, CA

Introduction: Xianqi Kong is a talented inventor based in Dollard-des-Ormeaux, Canada, known for his innovative contributions to various fields.

Latest Patents: Xianqi Kong holds several patents in the areas of renewable energy technologies and sustainable materials, showcasing his commitment to environmental innovation.

Career Highlights: With a background in engineering and a passion for problem-solving, Xianqi Kong has successfully developed groundbreaking solutions that have earned him recognition in the industry.

Collaborations: Throughout his career, Xianqi Kong has collaborated with leading research institutions and universities to further his inventions and bring them to market, demonstrating his dedication to advancing technology.

Conclusion: Xianqi Kong's inventive spirit and dedication to creating impactful solutions make him a notable figure in the world of innovation.